Infliximab therapy for Crohn's disease in a patient with chronic hepatitis B.
Ueno
Yoshitaka
Y
Department of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan.
Tanaka
Shinji
S
Shimamoto
Masaru
M
Miyanaka
Yoshihiro
Y
Hiyama
Toru
T
Ito
Masanori
M
Kitadai
Yasuhiko
Y
Yoshihara
Masaharu
M
Sumii
Masaharu
M
Chayama
Kazuaki
K
D000293:Adolescent; D000410:Alanine Transaminase / Q000097:blood; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D001219:Aspartate Aminotransferases / Q000097:blood; D003113:Colonoscopy; D003424:Crohn Disease / Q000150:complications* / Q000188:drug therapy* / Q000473:pathology; D004279:DNA, Viral / Q000097:blood; D005260:Female; D005765:Gastrointestinal Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006515:Hepatitis B virus / Q000187:drug effects / Q000235:genetics; D019694:Hepatitis B, Chronic / Q000150:complications* / Q000821:virology; D006801:Humans; D000069285:Infliximab; D012006:Rectovaginal Fistula / Q000150:complications / Q000000981:diagnostic imaging; D013997:Time Factors; D014463:Ultrasonography; D014775:Virus Activation
D000911:Antibodies, Monoclonal; D004279:DNA, Viral; D005765:Gastrointestinal Agents; D000069285:Infliximab; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase